Key Points for Patients with Myasthenia Gravis
Patients with myasthenia gravis must understand that this is a treatable autoimmune condition affecting muscle strength, requiring lifelong management and vigilance for potentially life-threatening respiratory complications.
Understanding Your Disease
Myasthenia gravis (MG) is an autoimmune disorder where your immune system attacks the communication points between nerves and muscles, causing fluctuating muscle weakness that worsens with activity and improves with rest 1, 2. The weakness typically affects:
- Eye muscles (drooping eyelids, double vision)
- Facial and throat muscles (difficulty chewing, swallowing, speaking)
- Limb muscles (difficulty climbing stairs, lifting arms)
- Breathing muscles (shortness of breath, respiratory failure in severe cases)
The disease is caused by antibodies attacking acetylcholine receptors (most common), muscle-specific kinase (MuSK), or lipoprotein-related protein 4 (LRP4) 1, 3. Your specific antibody type matters because it influences treatment choices and prognosis.
Critical Safety Information
Medications That Can Worsen Your Condition
You must avoid certain medications that can trigger severe worsening or myasthenic crisis 4, 5:
- Beta-blockers (heart/blood pressure medications)
- Fluoroquinolones (ciprofloxacin, levofloxacin - common antibiotics)
- Aminoglycosides (gentamicin, tobramycin - IV antibiotics)
- Macrolides (azithromycin, erythromycin - antibiotics)
- IV magnesium
Always inform every healthcare provider (including dentists, emergency room doctors, and surgeons) that you have MG before receiving any medication or anesthesia 1, 6.
Myasthenic Crisis Warning Signs
Seek immediate emergency care if you experience 4, 5:
- Increasing difficulty breathing or shortness of breath
- Severe difficulty swallowing or choking
- Inability to hold up your head
- Rapidly worsening weakness
Myasthenic crisis is a medical emergency requiring ICU-level care with potential need for breathing support 4, 5.
Treatment Expectations
First-Line Medications
Pyridostigmine (Mestinon) is typically the initial treatment, starting at 30 mg three times daily and gradually increasing to a maximum of 120 mg four times daily based on symptom response 4, 1, 5. However, approximately half of patients show minimal response to this medication alone 1, 7.
Corticosteroids (prednisone) are highly effective, with 66-85% of patients showing positive response 1, 7. Daily dosing (rather than alternate-day) is now standard practice 8. Your doctor will start steroids and gradually taper based on symptom improvement 4, 5.
Thymectomy (Thymus Gland Removal)
If you have generalized MG with acetylcholine receptor antibodies, thymectomy should be performed ideally within 2 years of disease onset 8, 3. This surgery can substantially reduce symptoms and is always indicated if a thymoma (thymus tumor) is present 1, 9, 6.
Advanced Treatments
For patients not adequately controlled with standard treatments, several options exist:
- Rituximab - now recommended for early use (within 1 year of generalized disease onset) based on recent evidence 8, 10
- Azathioprine - proven effective immunosuppressant 1, 11
- IVIG or plasmapheresis - for severe exacerbations or crisis 4, 5
- Newer targeted therapies - complement inhibitors (eculizumab, efgartigimod) and neonatal Fc receptor antagonists for refractory cases 1, 8, 12
Disease Course and Prognosis
Remission or stabilization is often possible after 2-3 years of treatment 1, 7. With modern therapy, MG has transformed from a disease with high mortality in the early 20th century to a condition where most patients achieve very good disease control 11.
Your symptoms will fluctuate - weakness typically worsens with activity, heat, stress, illness, and menstruation, and improves with rest and cool temperatures 1.
Pregnancy and Special Situations
If you are pregnant or planning pregnancy, specialized care is essential 3. MG can affect pregnancy management and newborns may temporarily have symptoms (neonatal MG) requiring monitoring 3, 13.
Stress, infections, and certain medical procedures can trigger worsening 9, 6. Plan ahead with your neurologist before any surgery, as special anesthetic precautions are required, especially if you have respiratory muscle weakness 1, 7.
Monitoring and Follow-Up
Regular neurological follow-up is mandatory 1. Your disease activity should be tracked using standardized scales (MG Activities of Daily Living, Quantitative MG Score) to guide treatment decisions 3, 13.
Even if you only have eye symptoms (ocular MG), you need ongoing monitoring as approximately 50% may progress to generalized disease 2. Early immunosuppression in ocular MG is increasingly recommended 10.
Living with MG
The goal of treatment is achieving minimal manifestations or complete remission with minimal side effects 3, 12. This is achievable for many patients with appropriate therapy.
Patient education and psychosocial support are integral to successful management 3. Consider joining patient support groups and maintaining open communication with your healthcare team about treatment goals and quality of life.
If you have positive antibodies but no symptoms, you still need education about myasthenic crisis risks in specific situations such as stress or administration of certain drugs 9, 6.